Massoud Saidijam

Summary

Publications

  1. Moradi M, Najafi R, Amini R, Solgi R, Tanzadehpanah H, Esfahani A, et al. Remarkable apoptotic pathway of Hemiscorpius lepturus scorpion venom on CT26 cell line. Cell Biol Toxicol. 2019;: pubmed publisher
  2. Ahmadyousefi Y, Malih S, Mirzaee Y, Saidijam M. Nucleic acid aptamers in diagnosis of colorectal cancer. Biochimie. 2019;156:1-11 pubmed publisher
    ..This review highlights recent advances in the development of nucleic acid aptamer-based methods for diagnosis, prognosis, and theranosis of colorectal cancer. ..
  3. Samadi P, Saki S, Dermani F, Pourjafar M, Saidijam M. Emerging ways to treat breast cancer: will promises be met?. Cell Oncol (Dordr). 2018;41:605-621 pubmed publisher
    ..By improving the clinical efficacy of current therapies and exploring new ones, it is anticipated that novel ways to overcome BC may become attainable. ..
  4. request reprint
    Moradi Sardareh H, Goodarzi M, Yadegar Azari R, Poorolajal J, Mousavi Bahar S, Saidijam M. Prostate cancer antigen 3 gene expression in peripheral blood and urine sediments from prostate cancer and benign prostatic hyperplasia patients versus healthy individuals. Urol J. 2014;11:1952-8 pubmed
    ..Increased level of this marker in urine sediments is more sensitive than blood for distinguishing between cancerous and non-cancerous groups.  ..
  5. Hasanvand D, Amiri I, Soleimani Asl S, Saidijam M, Shabab N, Artimani T. Effects of CeO2 nanoparticles on the HO-1, NQO1 and GCLC expression in the testes of diabetic rats. Can J Physiol Pharmacol. 2018;: pubmed publisher
    ..CNPs as Nrf2 up-regulator confers protection against oxidative stress in the testes of STZ-induced diabetic rats by upregulating HO-1, GCLC and NQO1 cyto-protective genes. ..
  6. Afshar S, Najafi R, Sedighi Pashaki A, Sharifi M, Nikzad S, Gholami M, et al. MiR-185 enhances radiosensitivity of colorectal cancer cells by targeting IGF1R and IGF2. Biomed Pharmacother. 2018;106:763-769 pubmed publisher
    ..miR-185 may act as a novel biomarker of radioresistance and may clinically enhance the radiation response of CRC. ..
  7. Malih S, Saidijam M, Malih N. A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy. Tumour Biol. 2016;37:1479-85 pubmed publisher
  8. request reprint
    Mahdavinezhad A, Mousavibahar S, Poorolajal J, Yadegarazari R, Jafari M, Shabab N, et al. Association between tissue miR-141, miR-200c and miR-30b and bladder cancer: a matched case-control study. Urol J. 2015;12:2010-3 pubmed
    ..001). There was a more expression rate of miR-200c, miR-141 and miR-30b in bladder cancer tissues than healthy adjacent control tissues. Further studies are needed to draw final conclusion. ..
  9. Jafarzadeh Samani Z, Sohrabi S, Shirmohammadi K, Effatpanah H, Yadegarazari R, Saidijam M. Evaluation of miR-22 and miR-20a as diagnostic biomarkers for gastric cancer. Chin Clin Oncol. 2017;6:16 pubmed publisher
    ..9 times) (P<0.05). The obtained results suggest miR-22 and miR-20a as good diagnostic biomarkers for early detection of GC. However more research is needed to investigate their efficacy. ..

More Information

Publications10

  1. Khoshinani H, Afshar S, Pashaki A, Mahdavinezhad A, Nikzad S, Najafi R, et al. Involvement of miR-155/FOXO3a and miR-222/PTEN in acquired radioresistance of colorectal cancer cell line. Jpn J Radiol. 2017;35:664-672 pubmed publisher
    ..Therefore, miR-222 and miR-155 can be suggested as good biomarkers of CRC radiation response. ..